BioSpace News Archive

Mitsubishi Tanabe Pharma America, Inc. is aware of recent external challenges facing the amyotrophic lateral sclerosis treatment landscape.

Spago Nanomedical has received declarations of intent from, among others, the Company’s largest owner, Peter Lindell, as well as all members of the Company’s board of directors and management team, regarding the intention to exercise the warrants of series TO12 (“Warrants”) for subscription of newly issued shares corresponding to their respective holdings of Warrants.

Coherus BioSciences, Inc. (Coherus, Nasdaq: CHRS) today announced that senior management will present at the upcoming TD Cowen 5th Annual Oncology Innovation Virtual Summit.

Altamira Therapeutics Ltd. today announced that highlights from the NASAR clinical trial with Bentrio® nasal spray in seasonal allergic rhinitis (SAR) have been published in video format on the social media channels of Allergy.

Cadrenal Therapeutics, Inc. will participate in a webcasted presentation and host one-on-one meetings with investors at the Lytham Partners Spring 2024 Investor Conference, taking place virtually on Thursday, May 30, 2024.

Providence Therapeutic Holdings Inc. and the Ontario Institute for Cancer Research, Ontario’s largest publicly funded cancer research institute delivering real-world solutions to people affected by cancer, announced the signing of a collaboration agreement for mRNA drug discovery and development.

LivaNova PLC today announced Vladimir Makatsaria, Chief Executive Officer, will present in a fireside chat at the Goldman Sachs Healthcare Conference in Miami, Florida.

Autonomix Medical, Inc. today announced the successful completion of an animal study evaluating the ability of targeted nerve ablation to impact tumor metastases and growth.

Melinta Therapeutics Announces Publication of the Outcomes by Candida Species from the ReSTORE Phase 3 trial and Recently Approved Rezafungin CLSI Breakpoints for Candida glabrata and Candida auris.

CD19, a protein prominently displayed on the surface of B cells, has become a focal point in therapeutic interventions for a spectrum of diseases, particularly cancer.